Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Debio 025 plus peginterferon alfa-2a and ribavirin in treatment-naive chronic hepatitis C genotype 1
2008-004605-34Phase 2Completed
- Sponsor
- Debiopharm
- Start
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of alisporivir in hepatitis C virus infection (4 arms), sponsored by Debiopharm. Primary endpoint: SVR24. Started Aug 2008; status: completed.
02
Drugs
alisporivir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2008-004605-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004605-34.